Alpha-Mannosidosis - Pipeline Review, H1 2012 New Report
Alpha-Mannosidosis - Pipeline Review, H1 2012, provides an overview of the Alpha-Mannosidosis therapeutic pipeline. This report provides information on the therapeutic development for Alpha-Mannosidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Alpha-Mannosidosis. 'Alpha-Mannosidosis - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites...
View full press release